Skip to main content

June 1, 2022

The GOAL-Hēm journey: Shared decision making and patient-centered outcomes

A novel, hemophilia-specific patient-reported outcome tool developed by Ardea Outcomes!

Ardea Outcomes collaborated with Takeda Pharmaceuticals to develop - GOAL-Hēm, an innovative, patient-centered outcome measure (PCOM) designed exclusively for people with hemophilia (PwH). Based on Goal Attainment Scaling (GAS), this tool allows individuals to set and monitor the attainment of individualized goals for treatment.

Discover how we worked hand-in-hand with skilled clinicians, caregivers, and patients to bring GOAL-Hēm to life.

Contact Us

Local with a global impact

Based in Nova Scotia, our culture reflects an East Coast Canadian ethos rooted in hard work and collegiality.

With over a decade of experience partnering with multinational sponsors on cutting-edge patient-centric research, the impact of our work is global.

Follow us for more: